PLoS ONE (Jan 2021)
Correction: Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0234103.].
PLoS ONE (Jan 2021)
[This corrects the article DOI: 10.1371/journal.pone.0234103.].